A study of the immune properties of human umbilical cord lining epithelial cells

Cytotherapy

Volumn 16, Issue 5, 2014, Pages 631-639

  Cai, Yi Jun ^a   Huang, Lin ^a   Leung, Tak Yeung ^b   Burd, Andrew ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cell therapy; Immune property; Umbilical cord epithelial cells; Wound healing

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CYTOKINE; GROWTH FACTOR; HLA DR ANTIGEN; HLA E ANTIGEN; HLA G ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIGEN EXPRESSION; ARTICLE; CELL ASSAY; CELLULAR IMMUNITY; EPITHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IN VITRO STUDY; INFLAMMATION; KERATINOCYTE; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MIXED LYMPHOCYTE CULTURE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL CORD; WESTERN BLOTTING; WOUND HEALING; CELL CULTURE; CYTOLOGY; IMMUNOLOGY; METABOLISM; PREGNANCY;

ANTIGENS, CD40; ANTIGENS, CD80; ANTIGENS, CD86; CELLS, CULTURED; EPITHELIAL CELLS; FEMALE; HUMANS; LYMPHOCYTE CULTURE TEST, MIXED; PREGNANCY; UMBILICAL CORD;

EID: 84897957798     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2013.10.008     Document Type: Article

References (41)

1. Huang L., Wong Y.P., Gu H., Cai Y.J., Ho Y., Wang C.C., et al. Stem cell-like properties of human umbilical cord lining epithelial cells and the potential for epidermal reconstitution. Cytotherapy 2011, 13:145-155.
2. Benichou G., Yamada Y., Yun S.H., Lin C., Fray M., Tocco G. Immune recognition and rejection of allogeneic skin grafts. Immunotherapy 2011, 3:757-770.
3. Klyushnenkova E., Mosca J.D., Zernetkina V., Majumdar M.K., Beggs K.J., Simonetti D.W., et al. Tcell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. JBiomed Sci 2005, 12:47-57.
4. Atoui R., Shum-Tim D., Chiu R.C. Myocardial regenerative therapy: immunologic basis for the potential "universal donor cells". Ann Thorac Surg 2008, 86:327-334.
5. Song J., Lei F.T., Xiong X., Haque R. Intracellular signals of T cell costimulation. Cell Mol Immunol 2008, 5:239-247.
6. Larsen C.P., Pearson T.C. The CD40 pathway in allograft rejection, acceptance, and tolerance. Curr Opin Immunol 1997, 9:641-647.
7. Weiss M.L., Anderson C., Medicetty S., Seshareddy K.B., Weiss R.J., VanderWerff I., et al. Immune properties of human umbilical cord Wharton's jelly-derived cells. Stem Cells 2008, 26:2865-2874.
8. Le Blanc K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 2003, 5:485-489.
9. Magatti M., De Munari S., Vertua E., Gibelli L., Wengler G.S., Parolini O. Human amnion mesenchyme harbors cells with allogeneic T-cell suppression and stimulation capabilities. Stem Cells 2008, 26:182-192.
10. Li C., Zhang W., Jiang X., Mao N. Human-placenta-derived mesenchymal stem cells inhibit proliferation and function of allogeneic immune cells. Cell Tissue Res 2007, 330:437-446.
11. Magatti M., De Munari S., Vertua E., Nassauto C., Albertini A., Wengler G.S., et al. Amniotic mesenchymal tissue cells inhibit dendritic cell differentiation of peripheral blood and amnion resident monocytes. Cell Transplant 2009, 18:899-914.
12. Selmani Z., Naji A., Gaiffe E., Obert L., Tiberghien P., Rouas-Freiss N., et al. HLA-G is a crucial immunosuppressive molecule secreted by adult human mesenchymal stem cells. Transplantation 2009, 87(9 Suppl):S62-S66.
13. Carosella E.D., Favier B., Rouas-Freiss N., Moreau P., Lemaoult J. Beyond the increasing complexity of the immunomodulatory HLA-G molecule. Blood 2008, 111:4862-4870.
14. Braud V.M., Allan D.S., O'Callaghan C.A., Soderstrom K., D'Andrea A., Ogg G.S., et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998, 391:795-799.
15. Nickoloff B.J., Turka L.A., Mitra R.S., Nestle F.O. Direct and indirect control of T-cell activation by keratinocytes. JInvest Dermatol 1995, 105(1 Suppl):25S-29S.
16. Otten H.G., Bor B., Ververs C., Verdonck L.F., De Boer M., De Gast G.C. Alloantigen-specific T-cell anergy induced by human keratinocytes is abrogated upon loss of cell-cell contact. Immunology 1996, 88:214-219.
17. Bal V., McIndoe A., Denton G., Hudson D., Lombardi G., Lamb J., et al. Antigen presentation by keratinocytes induces tolerance in human T cells. Eur J Immunol 1990, 20:1893-1897.
18. Gauglitz G.G., Zedler S., von Spiegel F., Fuhr J., von Donnersmarck G.H., Faist E. Functional characterization of cultured keratinocytes after acute cutaneous burn injury. PLoS One 2012, 7:e29942.
19. Burd A., Kwok C.H., Hung S.C., Chan H.S., Gu H., Lam W.K., et al. Acomparative study of the cytotoxicity of silver-based dressings in monolayer cell, tissue explant, and animal models. Wound Repair Regen 2007, 15:94-104.
20. Zhou Y., Gan S.U., Lin G., Lim Y.T., Masilamani J., Mustafa F.B., et al. Characterization of human umbilical cord lining derived epithelial cells and transplantation potential. Cell Transplant 2011, 20:1827-1841.
21. Forraz N., McGuckin C.P. The umbilical cord: a rich and ethical stem cell source to advance regenerative medicine. Cell Prolif 2011, 44(Suppl 1):60-69.
22. Coupel S., Giral-Classe M., Karam G., Morcet J.F., Dantal J., Cantarovich D., et al. Ten-year survival of second kidney transplants: impact of immunologic factors and renal function at 12 months. Kidney Int 2003, 64:674-680.
23. Doxiadis, de Fijter J.W., Mallat M.J., Haasnoot G.W., Ringers J., Persijn G.G., et al. Simpler and equitable allocation of kidneys from postmortem donors primarily based on full HLA-DR compatibility. Transplantation 2007, 83:1207-1213.
24. Gilks W.R., Bradley B.A., Gore S.M., Klouda P.T. Substantial benefits of tissue matching in renal transplantation. Transplantation 1987, 43:669-674.
25. Hunt J.P., Hunter C.T., Brownstein M., Hultman C.S., deSerres S., Bracey L., et al. Host priming, not target antigen type, decides rejection rate in mice primed with MHC II "knockout" cultured keratinocytes. JSurg Res 1998, 76:32-36.
26. Bilic G., Zeisberger S.M., Mallik A.S., Zimmermann R., Zisch A.H. Comparative characterization of cultured human term amnion epithelial and mesenchymal stromal cells for application in cell therapy. Cell Transplant 2008, 17:955-968.
27. Pratama G., Vaghjiani V., Tee J.Y., Liu Y.H., Chan J., Tan C., et al. Changes in culture expanded human amniotic epithelial cells: implications for potential therapeutic applications. PLoS One 2011, 6:e26136.
28. Weiss M.L., Medicetty S., Bledsoe A.R., Rachakatla R.S., Choi M., Merchav S., et al. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 2006, 24:781-792.
29. Somoza C., Lanier L.L. T-cell costimulation via CD28-CD80/CD86 and CD40-CD40 ligand interactions. Res Immunol 1995, 146:171-176.
30. Bugeon L., Dallman M.J. Costimulation of T cells. Am J RespirCrit Care Med 2000, 162(4 Pt 2):S164-S168.
31. Veit T.D., Vianna P., Chies J.A.B. HLA-G: from fetal tolerance to a regulatory molecule in inflammatory diseases. Curr Immunol Rev 2010, 6:1-13.
32. Aden N., Nuttall A., Shiwen X., de Winter P., Leask A., Black C.M., et al. Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosis. JInvest Dermatol 2010, 130:2191-2200.
33. Chang H., Brown C.W., Matzuk M.M. Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr Rev 2002, 23:787-823.
34. Govinden R., Bhoola K.D. Genealogy, expression, and cellular function of transforming growth factor-beta. Pharmacol Ther 2003, 98:257-265.
35. Yoshimura A., Muto G. TGF-beta function in immune suppression. Curr Top Microbiol Immunol 2011, 350:127-147.
36. Ferguson M.W., O'Kane S. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Philos Trans R Soc Lond B Biol Sci 2004, 359:839-850.
37. Conway K., Price P., Harding K.G., Jiang W.G. The molecular and clinical impact of hepatocyte growth factor, its receptor, activators, and inhibitors in wound healing. Wound Rep Reg 2006, 14:2-10.
38. Niessen F.B., Schalkwijk J., Vos H., Timens W. Hypertrophic scar formation is associated with an increased number of epidermal Langerhans cells. JPathol 2004, 202:121-129.
39. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003, 3:23-35.
40. Salmon-Ehr V., Ramont L., Godeau G., Birembaut P., Guenounou M., Bernard P., et al. Implication of interleukin-4 in wound healing. Lab Invest 2000, 80:1337-1343.
41. Brehm M.A., Shultz L.D. Human allograft rejection in humanized mice: a historical perspective. Cell Mol Immunol 2012, 9:225-231.